Clinical trial
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 30, 2013
- Completion date
- January 2, 2029
- Enrollment
- 800 (estimated)
- Sites
- 59
Conditions
As the registry lists them; a condition with its own page is linked.
juvenile idiopathic arthritis